Raffaele Lodi

Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy.

In vivo evidence of neuronal loss in the hypothalamus of narcoleptic patients.

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.

Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy.

Friedreich's ataxia: from disease mechanisms to therapeutic interventions.

Energy metabolism in migraine.

Proton magnetic resonance spectroscopy study of brain metabolism in obstructive sleep apnoea syndrome before and after continuous positive airway pressure treatment.

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

Narcolepsy-like syndrome in multiple sclerosis.

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.

Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

A combined a-EEG and MR spectroscopy study in term newborns with hypoxic-ischemic encephalopathy.

A new case of idiopathic hemiplegia hemiconvulsion syndrome.

Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.

Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy.

A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16.

Brain diffusion-weighted imaging in Friedreich's ataxia.

Magnetic resonance imaging and spectroscopy in the evaluation of neuromuscular disorders and fatigue.

Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome.

Secondary post-geniculate involvement in Leber's hereditary optic neuropathy.

Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging.

Imaging brain functional and metabolic changes in restless legs syndrome.

Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.

Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.

'Behr syndrome' with OPA1 compound heterozygote mutations.

Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.

Syndromic parkinsonism and dementia associated with OPA1 missense mutations.

Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy.

The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.

Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder.

Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy.

A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings.

Combined Cerebellar Proton MR Spectroscopy and DWI Study of Patients with Friedreich's Ataxia.

ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy.

Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.

Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.

Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy.

Voxel-based morphometry to detect effect of APOE on brain gray matter changes in Parkinson's Disease.

Metabolic Imaging in Prostate Cancer: Where We Are.

Is mitochondrial oxidative metabolism the right therapy target in early Huntington disease?

The effect of diffusion gradient direction number on corticospinal tractography in the human brain: an along-tract analysis.

White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.

Proton MR Spectroscopy in Patients With Sleep-Related Hypermotor Epilepsy (SHE): Evidence of Altered Cingulate Cortex Metabolism.

Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines.

Mitochondrial dysfunction in myotonic dystrophy type 1.

Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy.

Brain functional connectivity in sleep-related hypermotor epilepsy.

Cognitive Rehabilitation and Transcranial Direct Current Stimulation in a Patient with Posterior Cortical Atrophy: An fMRI Study.

Along-tract analysis of the arcuate fasciculus using the Laplacian operator to evaluate different tractography methods.

Stridor-related gray matter alterations in multiple system atrophy: A pilot study.

Effects of Light Treatment on Sleep, Cognition, Mood, and Behavior in Alzheimer's Disease: A Systematic Review.

Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain H-MRS and volumetric changes: A two- year retrospective follow-up study.

L-Dopa Modulation of Brain Connectivity in Parkinson's Disease Patients: A Pilot EEG-fMRI Study.

Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications.

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network.

COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment.

''Eye of tiger sign" mimic in patients with spastic paraplegia gene 7 (SPG7) mutations.

Major cerebral vessels involvement in patients with MELAS syndrome: Worth a scan? A systematic review.

IDH1 Non-Canonical Mutations and Survival in Patients with Glioma.

From Neurosurgical Planning to Histopathological Brain Tumor Characterization: Potentialities of Arcuate Fasciculus Along-Tract Diffusion Tensor Imaging Tractography Measures.

A Meta-Analysis of Brain DNA Methylation Across Sex, Age, and Alzheimer's Disease Points for Accelerated Epigenetic Aging in Neurodegeneration.

The clinical and prognostic role of ALK in glioblastoma.

IDH1 single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas.

Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.

Author response to the letter regarding the publication titled "Major cerebral vessels involvement in patients with MELAS syndrome: worth a scan? A systematic review".

The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.